But first, lets back up a little and cover some context
Why GLP1s Are Gaining Attention in Liver Disease GLP1 receptor agonists, including semaglutide and other analogs, exert multiple metabolic effects: they enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and promote weight loss
Patients taking Zepbound often use the medication as part of a long-term plan to reduce body weight under medical supervision, but lawsuits allege that some users developed serious digestive complications after starting treatment
Structural formula: MOUNJARO is a clear, colorless to slightly yellow, sterile solution for subcutaneous use
However, tirzepatide targets two hormone receptors instead of one, which may contribute to greater fat reduction and improved body composition in some individuals
Monitor Your Bodys Response : Pay attention to how your body responds to each treatment